Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

dc.contributor.authorJ. Bousquet
dc.contributor.authorA. Bedbrook
dc.contributor.authorW. Czarlewski
dc.contributor.authorG. L. Onorato
dc.contributor.authorS. Arnavielhe
dc.contributor.authorD. Laune
dc.contributor.authorE. Mathieu-Dupas
dc.contributor.authorJ. Fonseca
dc.contributor.authorE. Costa
dc.contributor.authorO. Lourenço
dc.contributor.authorM. Morais-Almeida
dc.contributor.authorA. Todo-Bom
dc.contributor.authorM. Illario
dc.contributor.authorE. Menditto
dc.contributor.authorG. W. Canonica
dc.contributor.authorL. Cecchi
dc.contributor.authorR. Monti
dc.contributor.authorL. Napoli
dc.contributor.authorM. T. Ventura
dc.contributor.authorG. De Feo
dc.contributor.authorW. J. Fokkens
dc.contributor.authorN. H. Chavannes
dc.contributor.authorS. Reitsma
dc.contributor.authorA. A. Cruz
dc.contributor.authorJ. da Silva
dc.contributor.authorF. S. Serpa
dc.contributor.authorD. Larenas-Linnemann
dc.contributor.authorJ. M. Fuentes Perez
dc.contributor.authorY. R. Huerta-Villalobos
dc.contributor.authorD. Rivero-Yeverino
dc.contributor.authorE. Rodriguez-Zagal
dc.contributor.authorA. Valiulis
dc.contributor.authorR. Dubakiene
dc.contributor.authorR. Emuzyte
dc.contributor.authorV. Kvedariene
dc.contributor.authorI. Annesi-Maesano
dc.contributor.authorH. Blain
dc.contributor.authorP. Bonniaud
dc.contributor.authorI. Bosse
dc.contributor.authorY. Dauvilliers
dc.contributor.authorP. Devillier
dc.contributor.authorJ. F. Fontaine
dc.contributor.authorJ. L. Pépin
dc.contributor.authorN. Pham-Thi
dc.contributor.authorF. Portejoie
dc.contributor.authorR. Picard
dc.contributor.authorN. Roche
dc.contributor.authorC. Rolland
dc.contributor.authorP. Schmidt-Grendelmeier
dc.contributor.authorP. Kuna
dc.contributor.authorB. Samolinski
dc.contributor.authorJ. M. Anto
dc.contributor.authorV. Cardona
dc.contributor.authorJ. Mullol
dc.contributor.authorH. Pinnock
dc.contributor.authorD. Ryan
dc.contributor.authorA. Sheikh
dc.contributor.authorS. Walker
dc.contributor.authorS. Williams
dc.contributor.authorS. Becker
dc.contributor.authorL. Klimek
dc.contributor.authorO. Pfaar
dc.contributor.authorK. C. Bergmann
dc.contributor.authorR. Mösges
dc.contributor.authorT. Zuberbier
dc.contributor.authorR. E. Roller-Wirnsberger
dc.contributor.authorP. V. Tomazic
dc.contributor.authorT. Haahtela
dc.contributor.authorJ. Salimäki
dc.contributor.authorS. Toppila-Salmi
dc.contributor.authorE. Valovirta
dc.contributor.authorT. Vasankari
dc.contributor.authorB. Gemicioğlu
dc.contributor.authorA. Yorgancioglu
dc.contributor.authorN. G. Papadopoulos
dc.contributor.authorE. P. Prokopakis
dc.contributor.authorI. G. Tsiligianni
dc.contributor.authorS. Bosnic-Anticevich
dc.contributor.authorR. O’Hehir
dc.contributor.authorJ. C. Ivancevich
dc.contributor.authorH. Neffen
dc.contributor.authorM. E. Zernotti
dc.contributor.authorI. Kull
dc.contributor.authorE. Melén
dc.contributor.authorM. Wickman
dc.contributor.authorC. Bachert
dc.contributor.authorP. W. Hellings
dc.contributor.authorG. Brusselle
dc.contributor.authorS. Palkonen
dc.contributor.authorC. Bindslev-Jensen
dc.contributor.authorE. Eller
dc.contributor.authorS. Waserman
dc.contributor.authorL. P. Boulet
dc.contributor.authorJ. Bouchard
dc.contributor.authorD. K. Chu
dc.contributor.authorH. J. Schünemann
dc.contributor.authorM. Sova
dc.contributor.authorG. De Vries
dc.contributor.authorM. van Eerd
dc.contributor.authorI. Agache
dc.contributor.authorI. J. Ansotegui
dc.contributor.authorM. Bewick
dc.contributor.authorT. Casale
dc.contributor.authorM. Dykewick
dc.contributor.authorM. Ebisawa
dc.contributor.authorR. Murray
dc.contributor.authorR. Naclerio
dc.contributor.authorY. Okamoto
dc.contributor.authorD. V. Wallace
dc.contributor.authorand The MASK study group
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.converis.publication-id40405896
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/40405896
dc.date.accessioned2022-10-27T11:57:47Z
dc.date.available2022-10-27T11:57:47Z
dc.description.abstractAimsMobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases.MethodsMASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients.StakeholdersInclude patients, health care professionals (pharmacists and physicians), authorities, patient's associations, private and public sectors.ResultsMASK is deployed in 23 countries and 17 languages. 26,000 users have registered.EU grants (2018)MASK is participating in EU projects (POLLAR: impact of air POLLution in Asthma and Rhinitis, EIT Health, DigitalHealthEurope, Euriphi and Vigour).Lessons learnt(i) Adherence to treatment is the major problem of allergic disease, (ii) Self-management strategies should be considerably expanded (behavioural), (iii) Change management is essential in allergic diseases, (iv) Education strategies should be reconsidered using a patient-centred approach and (v) Lessons learnt for allergic diseases can be expanded to chronic diseases.
dc.identifier.eissn2045-7022
dc.identifier.jour-issn2045-7022
dc.identifier.olddbid173136
dc.identifier.oldhandle10024/156230
dc.identifier.urihttps://www.utupub.fi/handle/11111/31011
dc.identifier.urnURN:NBN:fi-fe2021042822062
dc.language.isoen
dc.okm.affiliatedauthorValovirta, Erkka
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherBMC
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumberARTN 16
dc.relation.doi10.1186/s13601-019-0252-0
dc.relation.ispartofjournalClinical and Translational Allergy
dc.relation.volume9
dc.source.identifierhttps://www.utupub.fi/handle/10024/156230
dc.titleGuidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma
dc.year.issued2019

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s13601-019-0252-0.pdf
Size:
2.07 MB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF